Eurofins Biomnis
Driving innovation in specialized medical biology
Diagnostic aids
All contents
June 2024
Thyroid disorders and pregnancy
During pregnancy, the hypothalamic-pituitary-thyroid axis adapts to physiological changes in the pregnant woman and to the needs of the foetus. To do so, it is estimated that thyroid activity increases by around 50%. However, thyroid…
June 2024
Updated management of thyroid cancers
The incidence of thyroid cancers is on the rise: over the past 30 years, reported cases have multiplied sixfold in industrialised countries, mainly concerning “small” cancers. The proportion of papillary micro-cancers has risen from 5%…
News and Events
All news
Register now so you don't miss any invitations!
Register
À propos de Biomnis
[Partnership] For personalised treatment in oncology
A Word from our experts
Biological management of of hematological malignancies
Find our documents and information sheets
Find the documents (order form, clinical information sheet ...) available to you for a good management of the requested analysis
Exome sequencing in premature ovarian failure: More precise and personalised guidance for patients and couples (DS111-INTGB)
B59-INTGB - Test request form : Genetics of chronic and hereditary pancreatitis
Prenatal exome sequencing (DS108-INTGB)
Optimised diagnosis for fetal malformations
Sample calendar - Serum screening for Down’s syndrome in the 1st or 2nd trimester of pregnancy (D21-INTGB-2023)
Diagnostics of mycobacterial infections (DS1-INTGB)
Autoantibodies in the diagnosis and follow-up of auto-immune diseases (DS4-INTGB)
Press Kit 2021
Press area
All press releaseInternational presence
- Implantations Eurofins Biomnis
- Eurofins Biomnis Ireland & UK
- Correspondants Eurofins Biomnis
Eurofins Biomnis is present in many countries
Eurofins Biomnis serves hospitals, medical centres, public and private laboratories, pharmaceutical companies and clinical trial centres on a global scale and is particularly well established in the Middle-East, Europe and Asia.
contact us